Drug Repurposing During The COVID-19 Pandemic: Lessons For Expediting Drug Development And Access
Health Affairs · 2023
DOI: 10.1377/hlthaff.2022.01083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Affairs, 2023. Verfasst von Wesley Greenblatt und 2 weiteren Autor:innen. Beteiligte Einrichtung: Wesley Greenblatt, Harvard University, Boston Children's Hospital, and Massachusetts Institute of Technology, Boston, Massachusetts. Hauptthemen laut MEDLINE: Drug Repositioning, COVID-19. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Wesley Greenblatt, Harvard University, Boston Children's Hospital, and Massachusetts Institute of Technology, Boston, Massachusetts.
- Charu Gupta, University of California Los Angeles, Los Angeles, California.
- Jennifer Kao (jennifer.kao@anderson.ucla.edu), University of California Los Angeles.
Zitieren
APA
Greenblatt, W., Gupta, C., & Kao, J. (2023). Drug Repurposing During The COVID-19 Pandemic: Lessons For Expediting Drug Development And Access. Health Affairs. https://doi.org/10.1377/hlthaff.2022.01083
Vancouver
Greenblatt W, Gupta C, Kao J. Drug Repurposing During The COVID-19 Pandemic: Lessons For Expediting Drug Development And Access. Health Affairs. 2023. doi:10.1377/hlthaff.2022.01083
BibTeX
@article{Greenblatt2023,
author = {Greenblatt, Wesley and Gupta, Charu and Kao, Jennifer},
title = {Drug Repurposing During The COVID-19 Pandemic: Lessons For Expediting Drug Development And Access},
journal = {Health Affairs},
year = {2023},
doi = {10.1377/hlthaff.2022.01083}
}
EUVIMED